meldepliktige handler fra primærinnsidere

← Alle transaksjoner

ContextVision - Mandatory notification of trade - primary insider

ContextVision AB (CONTX) · publisert 2. november 2022 kl. 11:30 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Gerald Pötzsch CEOacquisition10 0008,71 NOK1. november 2022SE0014731154llm

Meldingstekst

STOCKHOLM - November 02 2022 - Gerald Pötzsch, CEO of ContextVision, has during the period of August 31[st] until November 1[st], 2022 purchased 10.000 shares in ContextVision AB at an average price of NOK 8,71 per share. After the transaction, Mr Pötzsch holds a total of 15.000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Gerald Pötzsch Relation to listed entity: CEO Trade: 10.000 shares Date: 01.11.2022 Average purchase price: NOK 8,71 per share Primary insider's total shareholdings post-purchase: 15.000 shares Primary insider's percentage shareholding post-purchase: 0,02% ### For further information, please contact ContextVision's CEO, Gerald Pötzsch, at +46 8 750 35 50 or gerald.potzsch@contextvision.com or visit www.contextvision.com (https://www.globenewswire.com/Tracker?data=3MaQGqfSt sB_Z2n6YL96mk -0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhVS qE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4 -54NJMeD5MzrIVSQFWmgmZB085ANCWw_ -3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaSX iPxhqyw==). ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X -ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting -edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.